154 related articles for article (PubMed ID: 26749192)
1. Current diagnosis and treatment of Castleman's disease.
González García A; Moreno Cobo MÁ; Patier de la Peña JL
Rev Clin Esp (Barc); 2016 Apr; 216(3):146-56. PubMed ID: 26749192
[TBL] [Abstract][Full Text] [Related]
2. [Multicentric Castleman disease not associated with HHV-8 and HIV viruses].
Forteski Dde F; Netto FC; Lomonte AB; dos Anjos BC; Zerbini MC; Zerbini CA
Rev Bras Reumatol; 2014; 54(4):326-9. PubMed ID: 25627230
[TBL] [Abstract][Full Text] [Related]
3. Angiofollicular lymph node hyperplasia resembling a spinal nerve sheath tumor: a rare case of Castleman's disease.
Stevens EA; Strowd RE; Mott RT; Oaks TE; Wilson JA
Spine J; 2009 Sep; 9(9):e18-22. PubMed ID: 19482516
[TBL] [Abstract][Full Text] [Related]
4. Siltuximab: a new option for the management of Castleman's disease.
Barquero N
Drugs Today (Barc); 2015 Jan; 51(1):21-8. PubMed ID: 25685858
[TBL] [Abstract][Full Text] [Related]
5. [Castleman's disease].
Larroche C; Cacoub P; Godeau P
Rev Med Interne; 1996; 17(12):1003-13. PubMed ID: 9008748
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
7. Human herpes virus-8-associated multicentric Castleman's disease in an HIV-positive patient presenting with relapsing and remitting hyponatraemia.
Sasaki H; Maeda T; Hara Y; Osa M; Imai K; Moriguchi K; Mikita K; Fujikura Y; Kaida K; Kawana A
Int J STD AIDS; 2015 Oct; 26(12):909-11. PubMed ID: 25504830
[TBL] [Abstract][Full Text] [Related]
8. Renal thrombotic microangiopathy associated with multicentric Castleman's disease. Report of two cases.
Lajoie G; Kumar S; Min KW; Silva FG
Am J Surg Pathol; 1995 Sep; 19(9):1021-8. PubMed ID: 7661275
[TBL] [Abstract][Full Text] [Related]
9. Review of siltuximab in the treatment of multicentric Castleman's disease.
Sarosiek S; Shah R; Munshi NC
Ther Adv Hematol; 2016 Dec; 7(6):360-366. PubMed ID: 27904739
[TBL] [Abstract][Full Text] [Related]
10. [Mediastinal angiofolicular lymphoid hyperplasia--Castleman's disease--case report].
Sousa V; Carvalho L
Rev Port Pneumol; 2006; 12(3):275-80. PubMed ID: 16967177
[TBL] [Abstract][Full Text] [Related]
11. Multicentric Castleman's disease in human immunodeficiency virus infection: two case reports.
Caroline Ribeiro Sales A; Romão de Souza Junior V; Iglis de Oliveira M; Azevedo Braga Albuquerque C; de Barros Campelo Júnior E; Sérgio Ramos de Araújo P
J Med Case Rep; 2018 May; 12(1):117. PubMed ID: 29728131
[TBL] [Abstract][Full Text] [Related]
12. Castleman's disease of the spleen.
Mantas D; Damaskos C; Dailiani P; Samarkos M; Korkolopoulou P
Acta Chir Belg; 2017 Jun; 117(3):203-208. PubMed ID: 27771992
[TBL] [Abstract][Full Text] [Related]
13. Multicentric Castleman's disease in HIV infection: a systematic review of the literature.
Mylona EE; Baraboutis IG; Lekakis LJ; Georgiou O; Papastamopoulos V; Skoutelis A
AIDS Rev; 2008; 10(1):25-35. PubMed ID: 18385778
[TBL] [Abstract][Full Text] [Related]
14. [Castleman's disease. Discussion related to case report].
Dănăilă C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2000; 104(3):133-41. PubMed ID: 12089914
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous Disorders Associated with Castleman's Disease.
Kim HJ; Han JH; Bang CH; Park KS; Cho SG; Yoo DS; Kim KM; Park HJ; Park YM; Lee JY; Lee JH
Acta Derm Venereol; 2019 Oct; 99(11):984-989. PubMed ID: 31282978
[TBL] [Abstract][Full Text] [Related]
16. Post renal transplant Castleman's disease resolved after graft nephrectomy: a case report.
Al Otaibi T; Al Sagheir A; Ludwin D; Meyer R
Transplant Proc; 2007 May; 39(4):1276-7. PubMed ID: 17524952
[TBL] [Abstract][Full Text] [Related]
17. Castleman's disease: from basic mechanisms to molecular therapeutics.
El-Osta HE; Kurzrock R
Oncologist; 2011; 16(4):497-511. PubMed ID: 21441298
[TBL] [Abstract][Full Text] [Related]
18. Castleman's Disease and Anticonvulsant Therapy: A Case of 52-Year-Old Female.
Alobud SH; Bukhamseen FM; Hashim TM; Al Dandan O; ALrefaee MA
Cureus; 2021 Dec; 13(12):e20480. PubMed ID: 35047299
[TBL] [Abstract][Full Text] [Related]
19. Impact of siltuximab on patient-related outcomes in multicentric Castleman's disease.
Sitenga J; Aird G; Ahmed A; Silberstein PT
Patient Relat Outcome Meas; 2018; 9():35-41. PubMed ID: 29391839
[TBL] [Abstract][Full Text] [Related]
20. Castleman's Disease: A Case Report of the Unicentric Type.
Gomez-Ramirez J; Posada M; Sanchez-Urdazpal L; Martin-Perez E; Del Campo L; Garcia I; Martin JL; Larrañaga E
Case Rep Surg; 2012; 2012():175272. PubMed ID: 22991681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
